Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sun Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

18 Jun 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Sun Pharmaceutical Industries Ltd (SUNPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Jun 2016 Thomson Reuters Stock Report 11 $25.00

Wright Industry Averages: Pharmaceuticals & Biotechnology (India)

Wright Investors' Service Industry Averages - Pharmaceuticals & Biotechnology (India). Wright Industry Averages provide calcu...

21 Jun 2016 Wright Reports 68 $169.00

Company Snapshot - Sun Pharmaceuticals Industries

A director at Sun Pharmaceuticals Industries bought 7,200 shares at 0.000INR and the significance rating of the trade was 52/...

10 Jun 2016 Directors Deals Ltd. 1 $12.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

09 Jun 2016 GlobalData 160 $300.00

MOSL: SUN PHARMA 4QFY16 (Buy)-A strong quarter-Management provides modest FY17 top line guidance

SUN PHARMA 4QFY16: A strong quarter; Management provides modest FY17 top line guidance (SUNP IN, Mkt Cap USD27.3b, CMP INR76...

01 Jun 2016 Motilal Oswal Securities Ltd. 10 $104.00

Spark Capital: 4QFY16 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 792)

4QFY16 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 792) How does our one year outlook change? ...

01 Jun 2016 Spark Capital Advisors(India) Private Limited 6 $46.00

Sun Pharmaceuticals (SUNP) - Qtr. Update - Dated - May 31, 2016

Sun Pharma (Bloomberg: SUNP IN, HOLD, TP – Rs 790, 4% upside from CMP of Rs 763) Sun Pharma’s (Sun) Q4 PAT was 5% below ou...

01 Jun 2016 Axis Capital Limited 9 $92.00

Sun Pharmaceutical Industries_Q4FY16 Result Flash Note

Low guidance on FY17 revenue growth of 8-10%, stiff competition on base business leading to price erosion and increased R&D w...

31 May 2016 IndiaNivesh Securities Pvt Ltd 2 $12.00

SUN.NS - Event Transcript of Sun Pharmaceutical Industries Ltd conference call, May 30, 2016 / 10:30PM ET

Edited Event Transcript of SUN.NS conference call, May 30, 2016 / 10:30PM ET Boston, May 31, 2016 (Thomson StreetEvents...

30 May 2016 Thomson Reuters StreetEvents 28 $75.00